ALN-AT3: Phase I data

A 2-part, European Phase I trial in healthy volunteers and patients with moderate to severe hemophilia A or B showed that

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE